Mangoceuticals Inc. (MGRX)
4.76
-0.84 (-15.00%)
At close: Feb 20, 2025, 3:59 PM
4.61
-3.15%
After-hours: Feb 20, 2025, 05:36 PM EST
undefined% (undefined)
| Bid | 4.5 |
| Market Cap | 23.27M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -5.7 |
| PE Ratio (ttm) | -0.84 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 4.99 |
| Volume | 219,527 |
| Avg. Volume (20D) | 104,891 |
| Open | 5.64 |
| Previous Close | 5.60 |
| Day's Range | 4.44 - 6.14 |
| 52-Week Range | 2.07 - 16.80 |
| Beta | undefined |
About MGRX
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc....
Sector Healthcare
IPO Date Mar 21, 2023
Employees 3
Stock Exchange NASDAQ
Ticker Symbol MGRX
Website https://www.mangorx.com
4 months ago
-10.68%
Mangoceuticals shares are trading higher after the...
Unlock content with
Pro Subscription
4 months ago
+26.55%
Mangoceuticals shares are trading higher after the company announced its oral semaglutide branded as "Slim" is now available on their website.
